Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.

Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.

Show other versions (1)

Bibliographic Details
Main Authors:	Novitzky, N, Thomas, V, Stubbings, H, Hale, G, Waldmann, H
Format:	Conference item
Published:	2004

Similar Items

Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.
by: Novitzky, N, et al.
Published: (2004)

T-cell depletion of stem cell grafts with campath-1H "in the bag" followed by cyclosporin immunosuppression remains a cost effective strategy in transplantation
by: Novitzky, N, et al.
Published: (2004)

In marrow aplasia reduced-intensity conditioning and T-cell depletion of cytokine mobilised stem cells provides good engraftment without GvHD
by: Novitzky, N, et al.
Published: (2006)

Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome.
by: Novitzky, N, et al.
Published: (2002)

T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
by: Novitzky, N, et al.
Published: (1997)

Ex vivo T-cell depletion of bone marrow grafts with campath 1 prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation.
by: Novitzky, N, et al.
Published: (1997)

Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts.
by: Novitzky, N, et al.
Published: (2005)

Myeloablative conditioning is well tolerated by older patients receiving T-cell depleted grafts
by: Novitzky, N, et al.
Published: (2005)

Outcome following T-cell depletion of allogeneic peripheral blood progenitor cells for transplantation
by: Novitzky, N, et al.
Published: (1997)

Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.
by: Novitzky, N, et al.
Published: (1999)

T-cell depletion of peripheral blood progenitor cell grafts is associated with effective protection from GVHD and rapid haematopoietic reconstitution.
by: Novitzky, N, et al.
Published: (1997)

Immune reconstitution following haematopoietic stem cell transplantation.
by: Davison, G, et al.
Published: (2000)

Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells.
by: Davison, G, et al.
Published: (2000)

Immune reconstitution following allogeneic bone marrow transplantation depleted of T-cells.
by: Davison, G, et al.
Published: (1998)

Immune reconstitution post T-CELL depleted allogeneic bone marrow transplantation
by: Davison, G, et al.
Published: (1998)

Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
by: Hale, G, et al.
Published: (1994)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
by: Hale, G, et al.
Published: (1988)

Addition of cyclosporin post transplantation decreases GvHD without enhancing the adverse effect of T-cell depletion with CAMPATH-1H "in the bag": The cape town experience
by: Novitzky, N, et al.
Published: (2003)

Substantial peripheral T-cell depletion before grafting is beneficial in islet transplantation.
by: Brons, I, et al.
Published: (1995)

Use of Ceprate CD34-positive selection system for depletion of T cells in allogeneic transplantation.
by: Hale, G, et al.
Published: (1997)

Excessive T-cell depletion adversely affects transplant-related mortality following allogeneic stem cell transplantation.
by: Chakraverty, R, et al.
Published: (2000)

CAMPATH-1 antibodies in stem-cell transplantation.
by: Hale, G, et al.
Published: (2001)

Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
by: Thiti Asawapanumas, et al.
Published: (2022-01-01)

T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
by: Jacobs, P, et al.
Published: (1994)

Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation.
by: Chakraverty, R, et al.
Published: (2001)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
by: Hale, G, et al.
Published: (1998)

T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
by: Jacobs, P, et al.
Published: (1994)

PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION
by: Slavin, S, et al.
Published: (1985)

T-cell depletion with Campath-1H "in the bag" for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival.
by: Chakrabarti, S, et al.
Published: (2003)

Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients
by: Milena Elimelakh, et al.
Published: (2007-08-01)

Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
by: Barge, R, et al.
Published: (2001)

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
by: Hale, G, et al.
Published: (2000)

BONE-MARROW TRANSPLANTATION FOR CHRONIC PHASE CML - THE ROLE OF T-CELL DEPLETION IN 1988
by: Mackinnon, S, et al.
Published: (1988)

Pure Red Cell Aplasia with Del(20q) Sensitive for Immunosuppressive Treatment
by: Anh Khoi Vo, et al.
Published: (2020-01-01)

Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
by: Cobbold, S, et al.
Published: (1986)

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation.
by: Chakrabarti, S, et al.
Published: (2003)

Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
by: Heit, W, et al.
Published: (1986)

RESULTS OF T-CELL DEPLETION WITH CAMPATH-1 IN BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)
by: Apperley, J, et al.
Published: (1985)

In vitro and in vivo depletion of T cells.
by: Arnold, R, et al.
Published: (1993)

Postrenal transplant anemia and pure red cell aplasia
by: Praveen Kumar Etta
Published: (2019-01-01)